C33H33F3N6O4S — CID 164873826
tert-butyl N-[(3R)-5-[[4-[3-(1,1-difluoroprop-2-enyl)diazirin-3-yl]phenyl]methyl]-8-fluoro-7-[5-(2-methylpent-4-yn-2-yl)-1,3,4-oxadiazol-2-yl]-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl]carbamate (PubChem CID 164873826) has the molecular formula C33H33F3N6O4S and a molecular weight of 666.73 g/mol. Its IUPAC name is tert-butyl N-[(3R)-5-[[4-[3-(1,1-difluoroprop-2-enyl)diazirin-3-yl]phenyl]methyl]-8-fluoro-7-[5-(2-methylpent-4-yn-2-yl)-1,3,4-oxadiazol-2-yl]-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl]carbamate.
| Compound Name | tert-butyl N-[(3R)-5-[[4-[3-(1,1-difluoroprop-2-enyl)diazirin-3-yl]phenyl]methyl]-8-fluoro-7-[5-(2-methylpent-4-yn-2-yl)-1,3,4-oxadiazol-2-yl]-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl]carbamate |
|---|---|
| PubChem CID | 164873826 |
| Molecular Formula | C33H33F3N6O4S |
| Molecular Weight | 666.73 g/mol |
| Exact Mass | 666.22 |
| IUPAC Name | tert-butyl N-[(3R)-5-[[4-[3-(1,1-difluoroprop-2-enyl)diazirin-3-yl]phenyl]methyl]-8-fluoro-7-[5-(2-methylpent-4-yn-2-yl)-1,3,4-oxadiazol-2-yl]-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl]carbamate |
| SMILES | C#CCC(C)(C)c1nnc(-c2cc3c(cc2F)SC[C@H](NC(=O)OC(C)(C)C)C(=O)N3Cc2ccc(C3(C(F)(F)C=C)N=N3)cc2)o1 |
| InChI | InChI=1S/C33H33F3N6O4S/c1-8-14-31(6,7)28-39-38-26(45-28)21-15-24-25(16-22(21)34)47-18-23(37-29(44)46-30(3,4)5)27(43)42(24)17-19-10-12-20(13-11-19)33(40-41-33)32(35,36)9-2/h1,9-13,15-16,23H,2,14,17-18H2,3-7H3,(H,37,44)/t23-/m0/s1 |
| InChIKey | IXKSTAFBSUYZAR-QHCPKHFHSA-N |
| XLogP | 7.15 |
| TPSA | 122.28 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 47 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 666.73 |
| LogP ≤ 5 | 7.15 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|